Article Text
Abstract
Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.
- cardiovascular system
- heart failure
- chemotherapy
- haematology (incl blood transfusion)
Statistics from Altmetric.com
Footnotes
Contributors ZA wrote the manuscript. ED obtained and formatted the pathology slides. JB obtained the karyotoype slide. NV critically revised the paper.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.